User contributions
Jump to navigation
Jump to search
- 05:42, 28 October 2015 diff hist -50 Talimogene laherparepvec (Imlygic)
- 05:41, 28 October 2015 diff hist 0 Talimogene laherparepvec (Imlygic) →References
- 05:40, 28 October 2015 diff hist +13 Talimogene laherparepvec (Imlygic) →General information
- 05:39, 28 October 2015 diff hist +1,524 N Talimogene laherparepvec (Imlygic) Created page with "==General information== Class/mechanism: Oncolytic Viral Therapy <br>Route: PO <br>Extravasation: n/a For conciseness and simplicity, HemOnc.org currently will focus on treat..."
- 21:46, 23 February 2012 diff hist +8 Colon cancer →Regimen
- 21:46, 23 February 2012 diff hist +437 Colon cancer →Regimen
- 08:30, 18 February 2012 diff hist +1 Breast cancer →Ixabepilone (Ixempra)
- 08:30, 18 February 2012 diff hist +23 Breast cancer →Single agents
- 08:28, 18 February 2012 diff hist +1 Breast cancer →References
- 08:28, 18 February 2012 diff hist +1,172 Breast cancer →Single agents
- 00:49, 18 February 2012 diff hist +857 N Breast cancer Created page with "==Adjuvant Therapy== ==Metastatic Disease== ===Single agents=== ====Halaven==== *Eribulin (Halaven) 1.4 mg/m2 intravenously over 2 to 5 minutes on Days 1 and 8 of a 21-day cy..."